Submission Details
| 510(k) Number | K954807 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 19, 1995 |
| Decision Date | December 21, 1995 |
| Days to Decision | 63 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K954807 is an FDA 510(k) clearance for the CEDIA T UPTAKE ASSAY, a Radioassay, Triiodothyronine Uptake (Class II — Special Controls, product code KHQ), submitted by Boehringer Mannheim Corp. (Concord, US). The FDA issued a Cleared decision on December 21, 1995, 63 days after receiving the submission on October 19, 1995. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1715.
| 510(k) Number | K954807 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 19, 1995 |
| Decision Date | December 21, 1995 |
| Days to Decision | 63 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | KHQ — Radioassay, Triiodothyronine Uptake |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1715 |